Published Sep 20, 2026, 7:40 PM ET · Updated 2 months ago · 1 source
Telix to Buy Isotope Maker ITM in Deal Worth Up to $2.35 Billion
bloomberg
·
Original Report
Australia’s Telix Pharmaceuticals Ltd. agreed to acquire ITM Isotope Technologies Munich SE in a deal worth as much as $2.35 billion, securing a major supplier of radioactive materials used in cancer treatments and adding a late-stage drug candidate.